The product risk is lower than the business-model risk. Amprius now has to prove that chemistry leadership survives outsourced manufacturing,
qualification-heavy adoption, and larger-customer bargaining power. If repeat programs fill contracted capacity, the model can scale elegantly; if partner quality, domestic
qualification, or customer conversion slip, the high starting valuation and
dilution risk can overwhelm real revenue growth.